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http://dx.doi.org/10.1016/j.asjsur.20Summary Background/Objective: Core needle biopsy (CNB) was widely used in the diagnosis
of ultrasound-detectable breast lesions. We aimed at assessing the diagnostic performance
differences between 14- and 16-gauge ultrasound-guided core biopsies.
Methods: This retrospective study enrolled patients receiving CNB from January 2001 to
December 2007. The results of 14- and 16-gauge breast CNBs were compared with pathology
reports of open surgical biopsy (OSB).
Results: A total of 1024 paired CNB and OSB results were obtained from 1732 CNB procedures in
1630 patients.Those CNB results reached 92.9% sensitivity, 99.7% specificity, 5.96% underesti-
mation, and 94.8% accuracy rates. There was no difference in sensitivity (p Z 0.17) or spec-
ificity (p Z 0.38) between 14- and 16-gauge needles. However, better overall accuracy
(p Z 0.02), less underestimation (p < 0.001), and lower false-negative (p Z 0.02) rates were
found for the 14-gauge CNB.
Conclusion: Regarding accuracy and underestimation rates, a 14-gauge needle is preferred to
a 16-gauge one in ultrasound-guided biopsies.
Copyright ª 2012, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.sive Breast Cancer Center, Changhua Christian Hospital, 135 Nanhsiao Street, Changhua, Taiwan.
org.tw (D.-R. Chen).
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84 H.-W. Lai et al.1. Introduction accuracy rates of CNB, and differences between resultsPercutaneous large core needle biopsy (CNB), as first
described by Parker et al1 in the early 1990s, has become
widely used as an alternative to open surgical biopsy
(OSB).1e5 During the past 10 years, with the increasing
experience of this procedure, ultrasound-guided CNB has
evolved as a highly sensitive, specific, and accurate method
for the diagnosis of breast cancer.5e8 Patients with
concordant image and CNB results benefit from reduced
discomfort and anxiety, as compared with OSB.
Despite a high concordance rate between CNB and
histologic results obtained at the subsequent open
biopsy,2,5 differences (varying from 0% to 18%)1e4,9in
pathologic findings still existed. The discordant results
varied, from initial CNB findings of atypia or ductal carci-
noma in situ (DCIS), upgraded to DCIS or invasive carcinoma
at surgical excision,10 to difficulty in distinguishing malig-
nancy from benign papillary lesions.9
Factors affecting the false-negative (FN) and underes-
timation rates include accurate targeting of the needle,
and the number and adequacy of samples obtained.11,12
Recent studies investigating needle core biopsy underesti-
mation rates have pointed to the potential variability
associated with the differences in needle gauges.7,13e15
There are still controversies as to whether the needle size
has an impact on the different underestimations among
various reported series.7,14e17
Currently, there is a lack of information about the
diagnostic difference between 14- and 16-gauge needles in
ultrasound-guided core biopsy for sonogram-detectable
breast lesions. Although in 1995, Nath et al18 reported
that biopsy samples obtained with a 14-gauge needle,
compared with a 16- or 18-gauge needle, provided more
accurate diagnostic results. The 16-gauge core needle was
still used widely by physicians in many different centers.
Studies focusing on the comparison of diagnostic efficacy
between 14- and 16-gauge biopsy needles were lacking.
Whether 14- and 16-gauge needles resulted in different
diagnostic yield in terms of sensitivity, specificity, FN,
false-positive (FP), and underestimation rates was still
unknown.
The purpose of this study was to examine the diagnostic
efficacy and underestimation rates of CNB in a series of
breast tumors sampled with 14- versus 16-gauge needles in
ultrasound-guided large core biopsies.2. Methods
2.1. Patients
A retrospective study was conducted in our hospital to
determine the accuracy and underestimation rates of CNB,
and the difference in results of 14- versus 16-gauge biopsy
needles. Data, on patients who received breast CNB during
the period of January 2001 to December 2007, were
retrospectively collected. The data collected included each
patient’s age, gender, number of samples per CNB proce-
dure, lesion size, and final OSB pathologic report. FN, FP,
sensitivity, specificity, underestimation, and overallfrom 14- versus 16-gauge needles were compared. Ethical
guidelines of the Declaration of Helsinki19 were followed
throughout.
2.2. Ultrasound-guided CNBs
Ultrasound-guided procedures were performed with the
patient in the supine or supine oblique position. Imaging
was performed with a high-resolution 5e12 MHz linear array
transducer (Voluson 530D and 730D, Kretz Technik, Zipf,
Austria), and recorded according to the Breast Image
Reporting and Data System.20 Biopsies were performed
using a freehand technique with a 14-gauge automated or
16-gauge Tru-Cut needle and a spring-loaded biopsy gun
(Magnum, Bard, Covington, GA, USA) under ultrasound
guidance.
Two breast surgeons with 20 years (D.-R. Chen) and 25
years (S.-T. Chen) of experience, who were also experts in
breast sonogram and CNB, conducted the entire biopsy
series. Specimens were obtained from each lesion. All CNB
specimens were evaluated and diagnosed byan experienced
breast pathologist. Determination of concordance between
the imaging and histopathologic findings in each case was
decided by the breast surgeon who performed the proce-
dure. Benign core biopsy results were considered concor-
dant when there were no imaging features suspicious of
malignancy and accurate targeting of the needle and
adequate samples had been obtained.
If pathology results revealed mucinous-like lesions,
papillary lesions, atypical findings, or discordance between
core pathology and imaging, then breast surgeons would
recommend OSB of the lesion. For those patients with
malignant findings from the CNB, a definite surgical inter-
vention was performed; patients with benign findings, who
did not receive surgical excision, were asked to return in 6
months for a follow-up examination. If no changes were
seen in the follow-up examination, then the lesions were
regarded as likely benign.
2.3. Definition of sensitivity, specificity, accuracy,
and underestimation
The histology of final surgical outcomes was compared to
the pathology findings of the CNB for assessment of sensi-
tivity, specificity, accuracy, and underestimation rates of
the procedure. Only lesions with preoperative CNB results
and subsequent OSB were calculated for diagnostic accu-
racy and underestimation. Results from the CNB and the
final surgical outcome were thoroughly reviewed and
compared by the breast surgeons for concordance. If the
CNB and the final surgical pathologic results were
compatible, the CNB was considered concordant.
The positive predictive value for malignancy of each
consecutively performed surgical excision was calculated
by including DCIS and other invasive breast cancer cases.
Underestimation was defined as an initial CNB-revealed
atypia, but with final surgical outcome upgraded to DCIS or
invasive carcinoma, or DCIS upgraded to infiltrating ductal
carcinoma (IDC).9 True negative (TN) was defined as initial
CNB showing a benign result, and OSB also revealing benign








<35 (%) 268/1730 (15.5)
35e45 (%) 567/1730 (32.8)
Needle gauge for core needle biopsy 85lesions. True positive (TP) was defined as initial CNB
showing a malignant result, and final surgical outcome also
confirming malignancy. FN was defined as initial CNB
showing a benign result, but OSB revealing malignancy. FP
was defined as initial CNB showing a malignant result, but
final surgical pathology revealing it to be benign.
Sensitivity was defined as the TPs divided by the sum of
TPs and FNs, i.e., sensitivity Z TP/(TP þ FN). Specificity
was defined as the TNs divided by the sum of TNs and FPs,
i.e., specificity Z TN/(TN þ FP). Accuracy was calculated
as TP and TN cases diagnosed by CNB at the ratio of total
cases, i.e., accuracy Z TP þ TN/(TP þ FN þ TN þ FP).>45 (%) 895/1730 (51.7)
Sample number




3 (%) 1161/1724 (67.3)
>3 (%) 563/1724 (32.7)
Tumor size (cm)
Mean (SD) 2.8 (2.0)2.4. Statistical methods
Data are expressed as mean  standard deviation (SD) for
continuous variables. Independent t tests were used for the
comparison of continuous variables. Categorical variables
were normally tested with the c2 test when appropriate. All
results with p < 0.05 were considered statistically signifi-
cant. All statistical analyses were performed with the SAS
software, version 9.1.Median 2.2
Range 0e18
Tumor size (cm)
<2 (%) 577/1560 (37.0)
2e4 (%) 701/1560 (44.9)
>4 (%) 282/1560 (18.1)
Diagnostic accuracy
Yes (%) 1 679 (96.9)
No (%) 53 (3.1)
Initial core needle biopsy result
Benign
Benign (%) 865 (49.9)
Atypical (%) 19 (1.1)
Malignant
Ductal carcinoma in situ (%) 75 (4.3)
Infiltrating ductal carcinoma (%) 728 (42.0)
Mucinous carcinoma (%) 13 (0.8)
Papillary carcinoma (%) 7 (0.4)
Other malignancies (%) 25 (1.4)
SD Z standard deviation.3. Results
A total of 1732 CNBs were performed on the 1630 patients.
The mean age of our patients was 46.4 years (range 13e93
years), with a mean tumor size of 2.8 cm (range
0.1e18 cm). The mean sample number per biopsy proce-
dure was 3.0 (range 1e10) (Table 1). Initial pathologic
results were 884 (51.0%) benign and 848 (49.0%) malignant
cases. A total of 1024 patients received further surgical
procedures due to pathology and imaging discordance,
requests on the part of patients, or the presence of
malignancy. Of our 884 patients with CNB benign lesions,
546 (61.8%) did not undergo further surgical excision and
were followed up in clinic (Fig. 1).
Results from the CNB and subsequent surgical proce-
dures were thoroughly reviewed and compared by the
breast surgeons for concordance (Table 2). Fifty-two cases
with initial CNB of benign lesions turned out to be malig-
nant at the final OSB (Table 3). There was one FP case, with
initial CNB indicating a malignant phyllodes tumor that was
found to be a benign phyllodes tumor after total excision.
The FN and FP rates in our study were, therefore, 5.1% and
0.1%, respectively. Among 61 underestimation cases, 48
were DCIS to IDC and 13 were atypical ductal hyperplasia to
DCIS or IDC, with an overall underestimation rate of 5.96%.
Our CNB result showed an overall 92.9% sensitivity, 99.7%
specificity, and 94.8% accuracy rate.
Among the 1024 CNB results with further SOB, 470
(45.9%) were performed by 14-gauge needles and 554
(54.1%) by 16-gauge needles. The FN rate of the 14- versus
the 16-gauge needle was 3.4% (16/470) versus 6.5% (36/
554), respectively (p Z 0.02). The only FP result was
derived from a 16-gauge needle biopsy. The underestima-
tion rate of the 14- versus the 16-gauge needle was 2.6%
(12/470) versus 8.8% (49/554), respectively (p < 0.001).
Sensitivity, specificity, and accuracy of the 14- versus the
16-gauge needle was 94.5% versus 91.9% (p Z 0.17), 100%versus 99.1% (pZ 0.38), and 96.6% versus 93.3% (pZ 0.02),
respectively (Table 3).
The mean weight of sample harvested per core was
12.7 mg (range 9.4e15.4 mg, SD 2.1) in the 14-gauge
automated gun needle and 5.3 mg (range 3.5e7.1 mg, SD
1.2) in the 16-gauge Tru-Cut core needle (p Z 0.002).
4. Discussion
The FN and underestimation rates of pathological findings
of CNB compared to those of OSB remain an issue in the
diagnosis of breast disease.1e5,9 Our CNB results, which
achieved 92.9% sensitivity, 99.7% specificity, 94.8%
Figure 1 Flow chart of patient allocation. F/U Z follow-up.
86 H.-W. Lai et al.accuracy, and 5.96% underestimation rates, are compatible
with the current reported series.5,7,11,14 Of special note is
that among our 52 “FN” cases, 13 had CNB atypical ductal
hyperplasia and 17 CNB papillary lesions (Table 3). In our
institution, atypical ductal hyperplasia and papillary lesions
were viewed as indications for further OSB. If we excluded
these 30 patients from the so-called “FN” results, the
sensitivity would reach 97%. Our current result supported
the fact that CNB is a sensitive, highly specific, and well-
accepted tool for the diagnosis of breast cancer in Taiwa-
nese women.
Although some studies7,16e18 discussed the different
results obtained by different gauge needle sizes, currently
limited information was available focusing on the compar-
ison of diagnostic yield between 14- and 16-gauge needle
core biopsy. Nath et al18 conducted a study on biopsy of
surgically removed specimens with three different gauges
(14, 16, and 18) of core needles. One satisfied core spec-
imen was obtained with each of the three different sizes of
needles, which was then compared the diagnosis obtained
with surgical excision biopsy result for diagnostic sensitivity
and specificity. The authors concluded that biopsy samples
obtained with a 14-gauge needle compared with a 16- or 18-
gauge needle provide the most accurate diagnosis, which
correlates with the diagnosis made with the surgicalTable 2 Comparison of core needle biopsy results and patholog
Core needle biopsy
Total (%) Total (%)
Benign (%) 884 (51.0) 338/884 (38
Malignant (%) 848 (49.0) 686/848 (80
Total (%) 1732 (100) 1024/1732 (59excision biopsy technique. However, Nath et al’s18 study was
limited by the fact that the CNB was not performed under
ultrasound guidance, and only one core of specimen was
obtained and compared. Furthermore, that study was con-
ducted at a time when the technique and instrument of
large core biopsy were still in the developmental phases,
and high-resolution ultrasound was still not available. In our
study, compared with the 16-gauge, the 14-gauge needle
had higher sensitivity (94.5% vs. 91.9%) and specificity (100%
vs. 99.1%); however, both were not statistically significant
(p values were 0.17 and 0.38, separately). Higher FN rate
(6.5% vs. 3.4%) and underestimation rate (8.8% vs. 2.6%)
were found in case of the 16-gauge than the 14-gauge
needle. Overall, a 14-gauge core needle is more accurate
than a 16-gauge needle (96.6% vs. 93.3%, pZ 0.02; Table 3).
The main influence of the various needle gauges
selected was the difference of volume retrieval from CNB.
The amount of tissue obtained varied with different gauges
of automated gun or vacuum-assisted biopsy device. In the
vacuum-assisted breast biopsy, 34e40 mg and 94e96 mg
per core tissue could be obtained with a 14- and an 11-
gauge needle,13,15,21 respectively, and an eight-gauge
vacuum-assisted needle results in a 39% increase in tissue
harvesting compared to an 11-gauge needle.14 Nath et al18
revealed that although 14-, 16-, and 18-gauge needles ally data from open surgical biopsy.
Open surgical biopsy
Benign (%) Malignant (%)
.2) 286/338 (84.6) 52/338 (15.4)
.9) 1/686 (0.1) 685/686 (99.9)
.1) 287/1024 (28.0) 737/1024 (72.0)
Table 3 Comparison of sensitivity, specificity, accuracy, and underestimation rates between 14- and 16-gauge core needles.
Total (n Z 1024) Needle gauge used p
14 (n Z 470) 16 (n Z 554)
Sensitivity (%) 685/737 (92.9) 277 /293 (94.5) 408 /444 (91.9) 0.17
Specificity (%) 286/287 (99.7) 177/177 (100) 109/110 (99.1) 0.38
Accuracy
Yes (%) 971/1024 (94.8) 454/470 (96.6) 517/554 (93.3) 0.02
No (%) 53/1024 (5.2) 16/470 (3.4) 37/554 (6.7)
Underestimation
Yes (%) 61/1024 (6.0) 12/470 (2.6) 49/554 (8.8) <0.001
No (%) 962/1024 (94.0) 457/470 (97.4) 505/554 (91.2)
False negative
Yes (%) 52/1024 (5.1) 16/470 (3.4) 36/554 (6.5) 0.02
No (%) 972/1024 (94.9) 454/470 (96.6) 518/554 (93.5)
False positive
Yes (%) 1/1024 (0.1) 0/470 (0) 1/554 (0.2) d
No (%) 1023/1024 (99.9) 470/470 (100) 553/554 (99.8)
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sample, biopsy sample obtained with the 14-gauge needle
is wider and longer compared with the specimens obtained
with the 16- and 18-gauge needles. However, in that study,
no detailed information about the weight or volume of
tissue was revealed per core of different gauges of biopsy.
In our breast center, the mean weight of sample harvested
per core was 12.7 mg with the 14-gauge automated gun
needle and 5.3 mg with the 16-gauge Tru-Cut core needle.
A 139.6% increase of tumor volume retrieval was found with
the 14-gauge automated core needle than with the 16-
gauge Tru-Cut needle per core specimen. A larger core
needle obtained more tissue, theoretically creating more
chance of correct tissue diagnosis. It is very likely that the
larger tumor volume retrieval by the 14-gauge core needle
may result in a more accurate diagnostic concordance than
that obtained by the smaller 16-gauge needle.
False positivity is the most erroneous result of CNB,
which may cause an unnecessary mastectomy and lead to
a possible legal problem. Compared with fine needle aspi-
ration cytology with an FP rate of <1%,22 false positivity in
CNB is a rarely reported issue. The only one FP result in our
series was obtained using a 16-gauge CNB, with an initial
diagnosis of a malignant phyllodes tumor, which turned out
to be a benign phyllodes tumor in the final surgical
pathology report. Fortunately, the patient received
a breast conservative surgery, without losing the whole
breast. This occurred at an earlier time when CNB was
initially used as an alternative diagnosis to OSB, and the
pathologist was not familiar with the pathologic results
from small core specimen. Since then, the pathologist
became more experienced with CNB specimen, and no
more FP results were found.
Here, we present our retrospective analysis of 1024
paired CNB and OSB results, derived from 1732 CNB
procedures from 1630 patients during a recent study
period (2001e2007) when high-resolution ultrasound was
available. We tried to delineate the diagnostic yield
between 14- and 16-gauge needles of ultrasound-guidedCNB by comparison of different parameters, and diagnostic
yields in terms of sensitivity, specificity, FP, FN, underes-
timation, and overall diagnostic accuracy rates. The data
presented here were relatively homogeneous with all CNBs
being performed under ultrasound guidance, without any
mammogram-guided or MRI-guided procedures to interfere
the current results. There was less variability in imaging
interpretation, biopsy methodology, and number of
samples obtained due to the fact that only two experienced
breast surgeons completed all the biopsies; this may have
eliminated the bias of a learning curve. Of interest, one
breast surgeon performed the CNB procedures using
14-gauge needles, while the other preferred using 16-gauge
needles. Although this study is retrospective and not
randomized, the data were rather homogenous and without
the selection bias of needle gauges. However, there were
still limitations in this study; about 62% of the benign CNB
lesions did not undergo further surgical excision to confirm
concordance between CNB and OSB. Furthermore, the
average number of tissue specimens retrieved during a 14-
gauge biopsy was 3.9 and that during a 16-gauge biopsy was
2.1. This could have resulted in bias in the interpretation of
the results comparing the two different gauges in the CNB.
As a whole, our current analysis demonstrated a good
diagnostic agreement between ultrasound-guided CNB and
subsequent surgical procedures. We also demonstrated that
the gauge of the needle influenced the accuracy of
pathology findings at CNB. In this analysis, both 14- and 16-
gauge needle core biopsies were associated with a more
than 90% sensitivity and accuracy rates for malignancy, and
a higher than 99% rate of specificity. In terms of accuracy
and underestimation rates, 14-gauge needles are
a preferred option, as compared with ultrasound-guided
biopsies that use 16-gauge needles.Acknowledgments
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